At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Intraceptdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Open-Label, Single-Arm Study of Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain
In Brief
A clinical study evaluating Intracept for Chronic Low Back Pain. Completed, enrolled 50 participants across 2 sites.
Detailed Summary
Prospective, single arm, open label, multi-center study to evaluated the effectiveness of intraosseous basivertebral nerve radiofrequency ablation using the Intracept System.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Low Back Pain
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 2017
Enrollment StartFeb 2018
Primary CompletionFeb 2020
TodayJul 2026
First PostedAug 29, 2017
Enrollment StartFeb 14, 2018
Primary CompletionFeb 17, 2020
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 8.8 years ago
Interventions
Intraceptdevice
Radiofrequency ablation of the basivertebral nerve using the Intracept System